أزينيل ٢٠٠ ملغ/٥ ملل معلق

Negara: Israel

Bahasa: Arab

Sumber: Ministry of Health

Beli Sekarang

Selebaran informasi Selebaran informasi (PIL)
17-07-2023

Bahan aktif:

AZITHROMYCIN AS DIHYDRATE 200 MG / 5 ML

Tersedia dari:

PFIZER PHARMACEUTICALS ISRAEL LTD

Kode ATC:

J01FA10

Bentuk farmasi:

POWDER FOR SUSPENSION

Rute administrasi :

PER OS

Diproduksi oleh:

HAUPT PHARMA LATINA S.R.L, ITALY

Kelompok Terapi:

AZITHROMYCIN

Indikasi Terapi:

Infections caused by susceptible organisms in lower respiratory tract including bronchitis and pneumonia, skin and soft tissue infections, otitis media, upper respiratory tract infections including sinusitis and pharyngitis, tonsilitis, also in the treatment of uncomplicated genital infections due to chlamydia trachomatis.

Tanggal Otorisasi:

2010-03-01

Selebaran informasi

                                Azenil Capsules, Azenil Suspension PIL CC 160723 Technical change
2023-0086619
ةرﺷﻧ
كﻠﮭﺗﺳﻣﻠﻟ
بﺟوﻣﺑ
ﺔﻣظﻧأ
ﺔﻟدﺎﯾﺻﻟا
)
تار
َ
ﺿﺣﺗﺳﻣ
(
-
1986
ق
ّ
وﺳ
ُ
ﯾ
ءاودﻟا
ﻖﻓو
ﺔﻔﺻو
بﯾﺑط
طﻘﻓ
تﻻوﺳﺑﻛ ™لﯾﻧﯾزأ
لﯾﻧﯾزأ
™
200
ﻎﻠﻣ
/
5
ﻖﻠﻌﻣ لﻠﻣ
:ﻰﻠﻋ ﺔﻟوﺳﺑﻛ لﻛ يوﺗﺣﺗ
ﯾزأ
ﺛ
نﯾﺳﯾﻣور
)
تاردﯾﮭﯾد لﻛﺷ ﻰﻠﻋ
(
250
ﻎﻠﻣ
) 250 mg
ihydrate
d
as
(
zithromycin
a لﻛ يوﺗﺣﺗ
5
:ﻰﻠﻋ ﻖﻠﻌﻣﻟا نﻣ لﻠﻣ
ﯾزأ
ﺛ
نﯾﺳﯾﻣور
)
تاردﯾﮭﯾد لﻛﺷ ﻰﻠﻋ
(
200
ﻎﻠﻣ
) 200 mg
ihydrate
d
as
zithromycin (
a
داوﻣ
:ﺔ
ّ
ﯾﺳﺎﺳﺣﻠﻟ ةرﯾﺛﻣو ﺔﻟﺎ
ّ
ﻌﻓ رﯾﻏ
ا
رظﻧ
دﻧﺑﻟا
2
تﺣﺗ
دﻧﺑﻟاو "ءاودﻟا تﺎﺑﻛرﻣ نﻣ مﺳﻗ نﻋ
ﺔﻣﮭﻣ تﺎﻣوﻠﻌﻣ"
6
."ﺔ
ّ
ﯾﻓﺎﺿإ تﺎﻣوﻠﻌﻣ"
أرﻗا
ا ﻰﺗﺣ ن
ّ
ﻌﻣﺗﺑ ةرﺷﻧﻟ
ءاودﻟا لﺎﻣﻌﺗﺳﺎﺑ ءدﺑﻟا لﺑﻗ كﻟذو
ﺎﮭﺗﯾﺎﮭﻧ
ﻟا هذھ يوﺗﺣﺗ .
ﻧ
تﻧﺎﻛ اذإ .ءاودﻟا نﻋ ةزﺟوﻣ
تﺎﻣوﻠﻌﻣ ﻰﻠﻋ ةرﺷ
ّ
ﯾﻓﺎﺿإ ﺔﻠﺋﺳأ كﯾدﻟ
.
ّ
ﻲﻟدﯾﺻﻟا ﻰﻟإ وأ بﯾﺑطﻟا ﻰﻟإ ﮫ
ّ
ﺟوﺗﻓ ﺔ
.كﻠﺟأ نﻣ جﻼﻌﻠﻟ ءاودﻟا اذھ فﺻ
ُ
و
ِ
طﻌﺗ ﻻ
ﮫ
ﻟ
نﯾرﺧﻶ
؛
مﮭﺑ
ّ
رﺿﯾ دﻗ ﮫ
ّ
ﻧﻷ
،
نﯾﺑ ﮫﺑﺎﺷﺗ كﻟ ادﺑ وﻟ ﻰﺗﺣ
.ﺔ
ّ
ﯾﺣﺻﻟا مﮭﺗﻟﺎﺣو كﺗﻟﺎﺣ
لﯾﻧﯾزأ
200
/ﻎﻠﻣ
5
ﻖﻠﻌﻣ لﻠﻣ
رﻣﻋ نﻣ لﺎﻔطﻷ
ّ
دﻌﻣ
6
.رﮭﺷأ
تﻻوﺳﺑﻛ لﯾﻧﯾزأ
نﻣ رﺛﻛأ نوﻧزﯾ نﯾذﻟا لﺎﻔطﻷ
ّ
دﻌﻣ
45
.ﻎﻠﻛ
1 .
َ
مﻟ
؟ءاوّ
دﻟا اذھ ّ
دﻋأ
•
جﻼﻌﻟ
ىودﻌﻟا تﻻﺎﺣ
ﺔﯾﺳﻔﻧﺗﻟا قرطﻟا ﻲﻓ رﺿ
                                
                                Baca dokumen lengkapnya
                                
                            

Dokumen dalam bahasa lain

Selebaran informasi Selebaran informasi Inggris 17-07-2023
Karakteristik produk Karakteristik produk Inggris 09-01-2022
Laporan Penilaian publik Laporan Penilaian publik Inggris 14-07-2019
Selebaran informasi Selebaran informasi Ibrani 17-07-2023